| FITB |
Report |
Adjusted EPS |
BEAT |
pred ~$1.01 vs. cons $0.98 |
MEDIUM |
| FITB |
Report |
GAAP EPS |
IN-LINE |
pred ~$0.85 vs. cons $0.84 |
MEDIUM |
| FITB |
Report |
Net Interest Income (NII) |
BEAT |
pred ~$2.28B vs. cons/guide-midpoint $2.225B |
MEDIUM |
| FITB |
Guide |
NIM exit-rate trajectory |
BETTER |
guide ~3.42% vs. cons ~3.40% (Q4 2026 exit rate) |
LOW |
| FITB |
Guide |
Cost synergy run-rate (Comerica integration) |
UNCHANGED |
guide ~$850M vs. cons $850M annualized run-rate (Q4 2026) |
MEDIUM |
| FITB |
Guide |
Share buyback resumption |
BETTER |
guide ~$300M/quarter vs. cons ~$200-250M/quarter (H2 2026) |
LOW |
| FITB |
Guide |
Net charge-offs (credit quality) |
BETTER |
guide ~30bps vs. cons ~33bps (Q3 2026) |
MEDIUM |
| FITB |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.0% |
— |
MEDIUM |
| FITB |
Return |
5-day cumulative residual |
+1.8% (FOLLOW-THROUGH) |
Sector backdrop has been beat-and-raise (CFG, BNY, M&T all posted NII/NIM upside and were rewarded with continued drift), and FITB's synergy run-rate confirmation plus NIM path toward 3.40% by year-end should support incremental 2026/2027 EPS estimate raises after the print rather than a fade. However, the stock's ~27% run into the print, elevated valuation, and the previously flagged negative Zacks Earnings ESP cap the magnitude of follow-through versus a cleaner, cheaper setup; a disappointment on buyback sizing or any Labor Day conversion caveat could clip gains, so follow-through is modest rather than explosive. |
MEDIUM |